— Know what they know.
Not Investment Advice

PCRX NASDAQ

Pacira BioSciences, Inc.
1W: +0.4% 1M: -5.2% 3M: -1.5% YTD: +3.1% 1Y: -0.2% 3Y: -18.8% 5Y: -56.4%
$25.21
+0.20 (+0.80%)
 
Weekly Expected Move ±4.5%
$23 $24 $25 $26 $27
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $991.6M mcap · 38M float · 1.45% daily turnover · Short 55% of daily vol

📊 Key Metrics

TTM
$746M
Revenue
+5.7% YoY
$15M
Net Income
+111.5% YoY
$180M
Free Cash Flow
+53.3% YoY
77.0%
Gross Margin
2.2%
Op. Margin
2.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE2.0%
ROA1.1%
ROIC1.8%

Valuation

P/E71.6
P/B1.5
EV/EBITDA10.3

Leverage

Debt/Equity0.61
Current Ratio5.04
Interest Cov.2.1x

Quality Scores

Piotroski F8/9
Altman Z2.01
Beneish M-3.08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms